Parametric Portfolio Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.85M | Sell |
39,164
-20,650
| -35% | -$1.5M | ﹤0.01% | 2226 |
|
|
2021
Q4 | $7.07M | Sell |
59,814
-21,717
| -27% | -$2.57M | ﹤0.01% | 1629 |
|
|
2021
Q3 | $10.9M | Buy |
81,531
+15,659
| +24% | +$2.1M | 0.01% | 1291 |
|
|
2021
Q2 | $10.7M | Buy |
65,872
+38,365
| +139% | +$6.21M | 0.01% | 1337 |
|
|
2021
Q1 | $2.21M | Buy |
27,507
+6,500
| +31% | +$522K | ﹤0.01% | 2719 |
|
|
2020
Q4 | $1.14M | Buy |
21,007
+3,438
| +20% | +$187K | ﹤0.01% | 2974 |
|
|
2020
Q3 | $349K | Buy |
17,569
+693
| +4% | +$13.8K | ﹤0.01% | 3427 |
|
|
2020
Q2 | $355K | Sell |
16,876
-1,924
| -10% | -$40.5K | ﹤0.01% | 3403 |
|
|
2020
Q1 | $230K | Sell |
18,800
-29,881
| -61% | -$366K | ﹤0.01% | 3492 |
|
|
2019
Q4 | $714K | Buy |
48,681
+35,418
| +267% | +$519K | ﹤0.01% | 3224 |
|
|
2019
Q3 | $177K | Buy |
13,263
+543
| +4% | +$7.25K | ﹤0.01% | 3737 |
|
|
2019
Q2 | $208K | Sell |
12,720
-2,953
| -19% | -$48.3K | ﹤0.01% | 3732 |
|
|
2019
Q1 | $268K | Buy |
+15,673
| New | +$268K | ﹤0.01% | 3596 |
|
|
2018
Q4 | – | Sell |
-14,466
| Closed | -$414K | – | 3939 |
|
|
2018
Q3 | $414K | Buy |
14,466
+2,359
| +19% | +$67.5K | ﹤0.01% | 3502 |
|
|
2018
Q2 | $331K | Buy |
+12,107
| New | +$331K | ﹤0.01% | 3517 |
|